Deep Tech Startups

Outrun Therapeutics is a preclinical biotech developing small molecule E3 ligase inhibitors to stabilise tumour suppressor proteins for treating cancer and other diseases. Its lead programme targets an E3 ligase in hard-to-treat solid tumours.

2 investors

Outset is a New Zealand-based deep tech venture firm and R&D campus that helps founders build and scale frontier technology companies globally, providing facilities, community, and capital. It runs Momentum, an opportunity fund backing New Zealand deep tech companies as they scale.

2 investors

Owlo develops patented optical imaging technology that enables non-invasive, real-time 3D imaging deep within biological tissue. The company targets applications in IVF, drug discovery, and ophthalmology.

2 investors

OXB is a contract development and manufacturing organization (CDMO) providing end-to-end services for cell and gene therapies, with expertise in lentiviral vectors, AAV, adenovirus, and other viral vector manufacturing. The company serves pharmaceutical companies, biotechs, and startups developing advanced therapies, with manufacturing facilities across the UK, US, and Europe.

2 investors

Oxford Ionics develops trapped-ion quantum computers using Electronic Qubit Control to integrate qubit trapping and control onto standard semiconductor chips. Its quantum processors are compact, field-upgradeable, data-centre ready, and integrate with computing stacks such as AWS and NVIDIA.

2 investors

Oxford Science Enterprises is a venture-building investment firm, working in partnership with the University of Oxford, that funds and creates companies based on scientific research from Oxford, Harwell and Culham. It provides capital and company-building support to spin ventures out of academic breakthroughs across deep science fields.

2 investors

Oxi-Tech Solutions develops a water sanitation system using Pulse Oxidation, a process that uses water and low-voltage electricity to eliminate bacteria and viruses without chemicals. The company positions its technology as a chemical-free alternative for producing pathogen-free water, with applications noted in the Agri-Tech sector.

2 investors

Oxipital AI builds AI-based machine vision technology, including its V-CORTX platform, cameras, and no-code dashboards, for inspection and vision-guided robotics applications. It targets machine builders and manufacturers, with a focus on food, agriculture, and other high-variability production environments.

2 investors

OXMIQ Labs is a Silicon Valley semiconductor startup developing AI chips, built by a team of GPU and AI architects. The company is building across the US and India.

2 investors

Pacific Biosciences develops long-read DNA and RNA sequencing platforms and kits for genomics research, including whole genome, targeted, epigenetic, and RNA sequencing applications. The company serves research institutions, clinical laboratories, and diagnostic organizations in genomics and life sciences.

2 investors

Palabra.ai provides an AI bot that adds real-time voice translation and captions to Microsoft Teams meetings, supporting 60+ languages with sub-1-second latency. It targets businesses running multilingual meetings, webinars, and vendor or customer calls, and offers custom glossaries and private cloud or on-premises deployment for enterprise customers.

2 investors

Pandorum develops tissue engineering and regenerative medicine products, including a bio-engineered cornea for corneal regeneration and 3D human liver organoids used as in vitro models for drug discovery. The company operates in the biotech and regenerative therapeutics space.

2 investors

Pangea Bio is a clinical-stage biotech company developing therapies that activate the TrkB receptor pathway to promote neuronal survival and synaptic plasticity. Its lead candidate OT-003 and follow-on OT-1xx series target central nervous system disorders such as neurological and neuropsychiatric diseases.

2 investors

Pangeo Subsea develops underwater sensing and imaging technology, including LiDAR metrology systems, a Sub-Bottom Imager, an Acoustic Corer, and the KATFISH towed synthetic aperture sonar. These products provide 3D data on subsea assets, infrastructure, stratigraphy, and hazards for underwater survey and inspection.

2 investors

Panome Bio provides metabolomics, proteomics, and multi-omics integration workflows along with a computational platform that analyzes and integrates diverse biological data types. It serves life science and biotechnology researchers looking to identify biomarkers and generate research insights.

2 investors

Parallel Robotics is an engineering R&D firm specializing in mechatronics, robotics, and mechanical design. It offers full-stack engineering services in these domains.

2 investors

PathoQuest is a contract research organization offering GMP-validated next-generation sequencing (NGS) quality control assays under its iDTECT brand for viral safety testing and genetic characterization of biopharmaceuticals. It serves global and emerging biopharma companies working on modalities such as monoclonal antibodies, viral vectors, cell therapies, vaccines, and RNA products, providing an animal-free alternative to traditional in vivo biosafety testing.</parameter> <parameter name="founders">[]

2 investors

Patronus AI is a frontier research lab building Digital World Models that predict and simulate agent actions in digital workflows to generate large-scale training simulations for frontier AI models. Its simulations span domains including research science, software development, customer service, product applications, and finance, aimed at advancing continual learning toward human-aligned AGI.

2 investors

Pave designs and builds space hardware, including propulsion systems, space-ready avionics, and dedicated engine test infrastructure. Founded in 2024, the company develops in-house spaceflight technology.

2 investors

Pearl Semiconductor develops timing products, including oscillators and clock generators, using analog/mixed-signal and CMOS-based semiconductor technology. Spun out of Si-Ware Systems in 2020, the company operates in the timing segment of the semiconductor industry with an offshore design center in Malaysia.

2 investors

PEP-Therapy is a biotechnology company developing peptide-based cancer therapeutics, with a lead product PEP-010 targeting cancers such as pancreatic and ovarian cancer. Its drug candidate induces apoptosis in cancer cells and has received FDA Orphan Drug Designation for pancreatic cancer.

2 investors

Peptomyc is a biotech company developing MYC inhibitors for cancer treatment, based on the Omomyc molecule, and is advancing them through preclinical and clinical trials. It operates in oncology drug development, with its research group linked to the Vall d'Hebron Institute of Oncology in Barcelona, Spain.

2 investors

Perceptron builds a promptable vision AI model for physical AI, giving machines spatial perception, physical reasoning, and real-time decision-making in real-world settings. The model is offered across industries and use cases via APIs or commercial licensing of its weights.

2 investors

Perceptyne builds semi-humanoid robots with a 7-DOF arm that combine vision, force, and tactile sensing with physical AI to automate repetitive industrial workflows such as picking, placing, bolting, inspecting, and assembly. The company targets manufacturers and industrial operations, developing its robots ground-up in India.

2 investors